NCT04803682

Brief Summary

This early phase I trial studies how well A Smoking Prevention Interactive Experience (ASPIRE) program and mentorship works in preventing smoking in high school students. ASPIRE is an online-based, youth-centered tobacco prevention and cessation program. The goal of this research study is to learn if training eleventh grade high school students to be tobacco-free role models and mentors for ninth grade high school students is possible and will positively influence the younger peers.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
94

participants targeted

Target at P75+ for early_phase_1

Timeline
Completed

Started Jan 2016

Longer than P75 for early_phase_1

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 8, 2016

Completed
3.3 years until next milestone

First Submitted

Initial submission to the registry

May 9, 2019

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 16, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 16, 2021

Completed
2 days until next milestone

First Posted

Study publicly available on registry

March 18, 2021

Completed
Last Updated

March 18, 2021

Status Verified

March 1, 2021

Enrollment Period

5.2 years

First QC Date

May 9, 2019

Last Update Submit

March 16, 2021

Conditions

Outcome Measures

Primary Outcomes (4)

  • Required number of participants should be 40 mentors and 100 mentees

    At least 40 mentors and 100 mentees.

    3 years

  • Number of participants required to complete baseline and post-intervention assessments should be 35 mentors and 80 mentees

    At least 80% completion rates.

    3 years

  • All participants are required to attend at least 5 of 7 sessions of mentor to mentees interactions

    At least 5 of 7 sessions of mentor/mentee interactions

    3 years

  • Participants with the ability to provide the level of satisfaction with the program

    Training program for mentors and overall program satisfaction. Seventeen-item rating scale (1 = not skilled at all to 7 = extremely skilled) about facets of mentoring.

    3 years

Secondary Outcomes (1)

  • Tobacco related knowledge among mentees

    3 years

Study Arms (1)

Prevention (ASPIRE, mentorship)

EXPERIMENTAL

Participants complete online ASPIRE course over 3.5-4 hours. HIGH SCHOOL MENTORS: Eleventh grade high school students receive mentor training over 4-5 hours on how to mentor ninth grade students. ALL STUDENTS: Mentors and mentees are paired up so that eleventh grade high school students mentor the ninth grade high school students over 30 minutes for 7 sessions about the different types of tobacco products (such as cigarettes, cigars, hookah, and so on) and the dangers of these products.

Behavioral: Preventive InterventionBehavioral: Questionnaire Administration

Interventions

Participate in ASPIRE and mentorship program

Also known as: PREVENTATIVE, Prevention, Prevention Measures, prophylaxis, PRYLX
Prevention (ASPIRE, mentorship)

Ancillary studies (pre and post questionnaire)

Prevention (ASPIRE, mentorship)

Eligibility Criteria

Age13 Years - 18 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Ages 13-18
  • Enrolled in grades nine or eleven
  • Speaks and understands English
  • Parent or legally authorized guardian (LAR) provide written consent for study participation
  • Student provides written assent for study participation

You may not qualify if:

  • Unable to speak and understand English
  • Lives in the same household with another participant in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

M D Anderson Cancer Center

Houston, Texas, 77030, United States

Location

Study Officials

  • Alexander V Prokhorov

    M.D. Anderson Cancer Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
early phase 1
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 9, 2019

First Posted

March 18, 2021

Study Start

January 8, 2016

Primary Completion

March 16, 2021

Study Completion

March 16, 2021

Last Updated

March 18, 2021

Record last verified: 2021-03

Locations